Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 38

    1.

    Breast cancer therapy for BRCA1 carriers: moving towards platinum standard?

    Imyanitov EN.

    Hered Cancer Clin Pract. 2009 Apr 20;7(1):8.

    PMID:
    19379506
    [PubMed]
    Free PMC Article
    2.

    Should all distal pancreatectomies be performed laparoscopically?

    Merchant NB, Parikh AA, Kooby DA.

    Adv Surg. 2009;43:283-300. Review.

    PMID:
    19845186
    [PubMed - indexed for MEDLINE]
    3.

    Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.

    Winter-Roach BA, Kitchener HC, Dickinson HO.

    Cochrane Database Syst Rev. 2009 Jul 8;(3):CD004706. Review.

    PMID:
    19588360
    [PubMed - indexed for MEDLINE]
    4.

    Clinical and pathologic differences between BRCA1-, BRCA2-, and non-BRCA-associated breast cancers in a multiracial developing country.

    Yip CH, Taib NA, Choo WY, Rampal S, Thong MK, Teo SH.

    World J Surg. 2009 Oct;33(10):2077-81.

    PMID:
    19649760
    [PubMed - indexed for MEDLINE]
    5.

    Anthracycline- and/or taxane-resistant breast cancer: results of a literature review to determine the clinical challenges and current treatment trends.

    Moreno-Aspitia A, Perez EA.

    Clin Ther. 2009 Aug;31(8):1619-40. Review.

    PMID:
    19808124
    [PubMed - indexed for MEDLINE]
    6.

    Gemcitabine and carboplatin treatment in patients with relapsing ovarian cancer.

    Sufliarsky J, Chovanec J, Svetlovska D, Minarik T, Packan T, Kroslakova D, Lalabova R, Helpianska L, Horvathova D, Sevcik L, Spacek J, Laluha A, Tkacova V, Malec V, Rakicka G, Magdin D, Jancokova I, Dorr A, Stresko M, Habetinek V, Koza I.

    Neoplasma. 2009;56(4):291-7.

    PMID:
    19473054
    [PubMed - indexed for MEDLINE]
    7.

    Budget impact analysis of ixabepilone used according to FDA approved labeling in treatment-resistant metastatic breast cancer.

    Ho J, Zhang L, Todorova L, Whillans F, Corey-Lisle P, Yuan Y.

    J Manag Care Pharm. 2009 Jul-Aug;15(6):467-75.

    PMID:
    19610679
    [PubMed - indexed for MEDLINE]
    Free Article
    8.

    Customized treatment in non-small-cell lung cancer based on EGFR mutations and BRCA1 mRNA expression.

    Rosell R, Perez-Roca L, Sanchez JJ, Cobo M, Moran T, Chaib I, Provencio M, Domine M, Sala MA, Jimenez U, Diz P, Barneto I, Macias JA, de Las Peñas R, Catot S, Isla D, Sanchez JM, Ibeas R, Lopez-Vivanco G, Oramas J, Mendez P, Reguart N, Blanco R, Taron M.

    PLoS One. 2009;4(5):e5133. Epub 2009 May 5.

    PMID:
    19415121
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    9.

    The preclinical natural history of serous ovarian cancer: defining the target for early detection.

    Brown PO, Palmer C.

    PLoS Med. 2009 Jul;6(7):e1000114. Epub 2009 Jul 28.

    PMID:
    19636370
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    10.

    Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma.

    Rabban JT, Barnes M, Chen LM, Powell CB, Crawford B, Zaloudek CJ.

    Am J Surg Pathol. 2009 Aug;33(8):1125-36.

    PMID:
    19440148
    [PubMed - indexed for MEDLINE]
    11.

    Contemplating chemosensitivity of basal-like breast cancer based on BRCA1 dysfunction.

    Ohta T, Wu W, Koike A, Asakawa H, Koizumi H, Fukuda M.

    Breast Cancer. 2009;16(4):268-74. Epub 2009 May 21.

    PMID:
    19459031
    [PubMed - indexed for MEDLINE]
    12.

    Epithelial ovarian cancer: role of pegylated liposomal Doxorubicin in prolonging the platinum-free interval and cancer antigen 125 trends during treatment.

    Tanguay JS, Ansari J, Buckley L, Fernando I.

    Int J Gynecol Cancer. 2009 Apr;19(3):361-6.

    PMID:
    19407560
    [PubMed - indexed for MEDLINE]
    13.

    HER2 testing to manage patients with breast cancer or other solid tumors.

    Seidenfeld J, Samsom DJ, Rothenberg BM, Bonnell CJ, Ziegler KM, Aronson N.

    Evid Rep Technol Assess (Full Rep). 2008 Nov;(172):1-362. Review.

    PMID:
    19408965
    [PubMed - indexed for MEDLINE]
    Free Article
    14.

    Current data of targeted therapies for the treatment of triple-negative advanced breast cancer: empiricism or evidence-based?

    Petrelli F, Cabiddu M, Ghilardi M, Barni S.

    Expert Opin Investig Drugs. 2009 Oct;18(10):1467-77. Review.

    PMID:
    19737114
    [PubMed - indexed for MEDLINE]
    15.

    Candidate serous cancer precursors in fallopian tube epithelium of BRCA1/2 mutation carriers.

    Shaw PA, Rouzbahman M, Pizer ES, Pintilie M, Begley H.

    Mod Pathol. 2009 Sep;22(9):1133-8. Epub 2009 Jun 19.

    PMID:
    19543244
    [PubMed - indexed for MEDLINE]
    Free Article
    16.

    Exemestane: a review of its use in postmenopausal women with breast cancer.

    Deeks ED, Scott LJ.

    Drugs. 2009;69(7):889-918. doi: 10.2165/00003495-200969070-00007. Review.

    PMID:
    19441873
    [PubMed - indexed for MEDLINE]
    18.

    Triple-negative breast cancer: novel therapies and new directions.

    Pal SK, Mortimer J.

    Maturitas. 2009 Aug 20;63(4):269-74. Epub 2009 Jul 25. Review.

    PMID:
    19632796
    [PubMed - indexed for MEDLINE]
    19.

    [A retrospective analysis of trastuzumab-based therapy in metastatic breast cancer patients at Masaryk Memorial Cancer Institute. Identification of predictive factors].

    Svoboda M, Grell P, Simícková M, Fabian P, Petráková K, Palácová M, Macková D, Trojanec R, Hajdúch M, Pavlík T, Nenutil R, Vyzula R.

    Klin Onkol. 2008;21(6):348-58. Czech.

    PMID:
    19382598
    [PubMed - indexed for MEDLINE]
    20.

    Role of BRCA1, HSD17B1 and HSD17B2 methylation in breast cancer tissue.

    Bhavani V, Srinivasulu M, Ahuja YR, Hasan Q.

    Cancer Biomark. 2009;5(4):207-13.

    PMID:
    19729830
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk